When the same team revisited the T-ALL subgroup with mono-allelic activation of TAL1, they discovered that the aberrant allele acquired a 20-kb long SE accommodating binding sites for a few major leukemogenic TFs, including RUNX1, GATA-3 and TAL1 itself (96). The gene discussed is RUNX1; the disease is acute lymphoblastic leukemia.